NASDAQ: CVRXCvrx Inc Stock Ownership - Who owns Cvrx?
Insider buying vs selling
Have Cvrx Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Joseph P. Slattery | Director | 2024-08-15 | 3,000 | $8.10 | $24.30kBuy |
| Joseph P. Slattery | Director | 2024-08-08 | 3,000 | $8.24 | $24.72kBuy |
| Joseph P. Slattery | Director | 2024-08-06 | 2,500 | $9.09 | $22.73kBuy |
| Kevin Hykes | PRES CEO | 2024-08-05 | 30,000 | $8.36 | $250.77kBuy |
| Craig E. Palmer | SVP U.S. SALES | 2024-03-25 | 379 | $0.24 | $89.82Buy |
| Craig E. Palmer | SVP U.S. SALES | 2024-03-25 | 151 | $0.24 | $35.79Buy |
| Craig E. Palmer | SVP U.S. SALES | 2024-03-25 | 404 | $0.24 | $95.75Buy |
| Johnson Johnson | 10% Owner | 2024-02-29 | 142 | $1.19 | $168.41Buy |
| Johnson Johnson | 10% Owner | 2024-02-29 | 442 | $1.19 | $524.21Buy |
| Johnson Johnson | 10% Owner | 2024-02-29 | 300 | $0.24 | $71.10Buy |
CVRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CVRX insiders and whales buy or sell their stock.
CVRX Shareholders
What type of owners hold Cvrx Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Johnson Johnson | 34.88% | 7,599,005 | $66.72M | Insider |
| Johnson Johnson | 18.84% | 4,103,430 | $36.03M | Institution |
| Johnson Innovatio Johnson | 16.05% | 3,495,575 | $30.69M | Insider |
| Nea Management Company LLC | 10.88% | 2,370,542 | $20.81M | Institution |
| Nea Partners 10 L P | 10.10% | 2,200,855 | $19.32M | Insider |
| New Enterprise Associates 10 L P | 9.30% | 2,026,083 | $17.79M | Insider |
| Geoffrey B. Pardo | 8.40% | 1,829,022 | $16.06M | Insider |
| Kirk G. Nielsen | 7.86% | 1,711,355 | $15.03M | Insider |
| Glaxosmithkline PLC | 4.62% | 1,007,583 | $8.85M | Insider |
| Mudit K. Jain | 4.30% | 936,783 | $8.22M | Insider |
CVRX vs Medical Device Stocks
Cvrx Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.